Palantir: The Earnings Were Otherworldly. Chasing the 40% Rally Is Not.

What more do investors want from Palantir?

The company just delivered its tenth consecutive earnings beat. Revenue jumped 93% year-over-year to $1.94 billion, blowing past the $1.80 billion estimate. Adjusted EPS of $0.41 came in well above the $0.34-to-$0.35 consensus. Net income hit $1.07 billion, a 55% margin. U.S. commercial revenue surged 149% year-over-year. Management raised full-year guidance to between $8.15 billion and $8.16 billion, implying more than 80% growth for the fiscal year. CEO Alex Karp called the quarter "otherworldly".

The pre-July narrative that Palantir's AI growth was running out of steam or that its valuation was unsustainable has been thoroughly dismantled. The stock, which had shed roughly 29% year-to-date on those fears, ripped roughly 40% over five trading days. It gained another 10.3% on Friday, August 7, closing near $172 on heavy volume.

Bank of America, which had maintained a Buy rating through the selloff, reaffirmed its $255 target on Friday — based on a 15x enterprise multiple applied to 2035 estimates. That is a long-term compounder framework, not a near-term entry signal.

The thesis was confirmed. The entry timing, however, is a different story.

The Fundamentals Are Legitimate

I'm not going to soften the numbers here. Palantir's operating profile is exceptional by any measure. Gross margins sit at 84.8%. Operating margins are at 42.8%. Free cash flow margins are 51.5%, with $3.36 billion generated over the trailing twelve months. Return on invested capital is 32.6%, and return on equity is 38.4%. The company carries $9.2 billion in cash and near-zero debt.

The Rule of 40 — a software industry benchmark that adds revenue growth rate to profit margin to gauge whether a company is growing fast enough to justify its profitability trade-off — came in at 155% for the quarter. A score above 40 is considered excellent. Palantir scored 155.

U.S. commercial revenue of $764 million in the quarter represents a 380% compound increase since 2024, per Karp's own calculation. The remaining U.S. commercial deal value more than doubled year-over-year to $6.24 billion. There are 220 deals of at least $1 million, 98 of at least $5 million, and 73 of at least $10 million. This isn't a pilot program that happened to have a good quarter. It's a scaling revenue engine.

Where the Valuation Gets Uncomfortable

Here's where the conversation changes. The stock trades at a forward P/E of 382 times. Its trailing P/E is 137x, enterprise value to EBITDA is 152x, and price-to-sales is 67x. Even by growth-stock standards, these multiples demand a near-flawless execution case for the next several years.

The PEG ratio — which divides the P/E by the revenue growth rate to give a sense of whether the premium is commensurate with growth — sits at 0.48. That looks cheap. But the PEG ratio is most useful when comparing companies within a reasonable valuation range. At 382x forward earnings, even 90% growth doesn't erase the sensitivity to any deceleration. A single quarter in the 50s or low 60s for revenue growth, instead of the current 90s, would send the stock reeling.

BofA's $255 target is built on seven-year-out estimates. It captures the long-term thesis, not the question of whether buying at $172 after a 40% five-day pop is a prudent entry.

The Moat Holds — For Now

Palantir's competitive position is real, not aspirational. Its AI Platform connects large language models to customer-specific data while keeping that data on the client's side. In an era where enterprises are increasingly worried about proprietary information becoming training data for their competitors, Palantir's "AI sovereignty" framing is a genuine differentiator. The government relationships, built over more than a decade and reinforced by massive multi-year contracts, create switching costs that new entrants simply can't replicate.

The bear case — that AI commoditization or cloud providers building in-house tools will eventually erode Palantir's pricing power — is a longer-horizon risk, not a near-term one. The current quarter shows the opposite: larger deals, deeper client penetration, and accelerating commercial adoption. But "the moat holds" is not the same as "any entry price is justified."

The Price Action Is Sending a Warning

The technical picture on Friday painted an overheated setup. The RSI (relative strength index, a momentum oscillator that flags overbought conditions above 70) was at 72.8. The stock was trading 30% above its 50-day moving average of $132.60 and 13% above its 200-day moving average of $152.28. Five-day volume ran at 76.7 million shares with a turnover of nearly $13 billion.

Friday's 10% gain was partly short covering — bearish positions being liquidated as the price moved against them — and partly broader tech rally momentum following a weak jobs report that reduced the odds of a near-term Federal Reserve rate hike. Neither dynamic is a reflection of new fundamental information. They're liquidity mechanics.

The stock's 52-week range is $106 to $208. At $172, it has recovered most of its year-to-date loss, down just 3% for the year. But it's still 17% below its 52-week high.

What an Investor Does

The Palantir thesis is intact. The growth, margins, cash flow, and competitive position all pass the fundamental gates. The market's pre-July pessimism was overdone, and the Q2 results proved it.

But I don't think chasing a 40% post-earnings rally into overbought technical territory is the right move. The thesis is a medium-to-long-term conviction. You don't need to enter at the peak of the liquidity-driven pop.

I'd wait for the dust to settle. A pullback toward the $150 to $155 range — near the 200-day moving average and the area where the stock consolidated before earnings — would offer a significantly better risk/reward. If the stock holds above $140 on a dip and volume dries up on the selloff, that would be confirmation that the selling exhaustion is real and the trend has flipped.

For investors who already own the position, there's no need to trim. The fundamentals support holding through volatility. But adding aggressively at current levels after a week that saw the stock surge roughly 40% is arguably chasing.

I would reassess the long-term view if the next two quarters show revenue growth decelerating into the 50s or 60s, if U.S. commercial growth fails to sustain triple-digit momentum, or if the raised full-year guidance is missed. Until then, the thesis stands. The patience to buy it at a reasonable price is the separate skill.

Don't let the FOMO override the risk management. The best compounders reward patience, not panic buying.